Biogen Inc. (0R1B.L)
USD 117.99
(1.06%)
USD 117.99
(1.06%)
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2023 | 7.33 Billion USD | 10.95% |
| 2022 | 6.61 Billion USD | -13.01% |
| 2021 | 7.6 Billion USD | -2.87% |
| 2020 | 7.82 Billion USD | 22.94% |
| 2019 | 6.36 Billion USD | 7.26% |
| 2018 | 5.93 Billion USD | 0.03% |
| 2017 | 5.93 Billion USD | -8.87% |
| 2016 | 6.51 Billion USD | -0.13% |
| 2015 | 6.52 Billion USD | 1014.41% |
| 2014 | 585.19 Million USD | -1.8% |
| 2013 | 595.92 Million USD | -47.76% |
| 2012 | 1.14 Billion USD | 7.21% |
| 2011 | 1.06 Billion USD | -11.59% |
| 2010 | 1.2 Billion USD | 9.42% |
| 2009 | 1.09 Billion USD | -1.18% |
| 2008 | 1.11 Billion USD | -28.78% |
| 2007 | 1.56 Billion USD | 1516.42% |
| 2006 | 96.69 Million USD | 122.57% |
| 2005 | 43.44 Million USD | -94.89% |
| 2004 | 850.3 Million USD | -4.17% |
| 2003 | 887.27 Million USD | 1997.66% |
| 2002 | 42.29 Million USD | -48.52% |
| 2001 | 82.16 Million USD | -24.85% |
| 2000 | 109.32 Million USD | -3.31% |
| 1999 | 113.06 Million USD | 82.8% |
| 1998 | 61.84 Million USD | -32.44% |
| 1997 | 91.55 Million USD | 38.15% |
| 1996 | 66.27 Million USD | 92.13% |
| 1995 | 34.49 Million USD | 0.0% |
| 1994 | - USD | 0.0% |
| 1993 | - USD | 0.0% |
| 1992 | - USD | 0.0% |
| 1991 | - USD | 0.0% |
| 1990 | - USD | 0.0% |
| 1989 | - USD | -100.0% |
| Year | Total Debt | Total Debt Growth |
|---|---|---|
| 2024 Q1 | 6.94 Billion USD | -5.34% |
| 2024 Q2 | 6.85 Billion USD | -1.35% |
| 2024 Q3 | 4.9 Billion USD | -2.94% |
| 2023 Q3 | 7.71 Billion USD | 17.09% |
| 2023 Q2 | 6.58 Billion USD | -0.31% |
| 2023 FY | 7.33 Billion USD | 10.95% |
| 2023 Q1 | 6.6 Billion USD | -0.07% |
| 2023 Q4 | 7.33 Billion USD | -4.89% |
| 2022 Q1 | 7.58 Billion USD | -0.21% |
| 2022 FY | 6.61 Billion USD | -13.01% |
| 2022 Q4 | 6.61 Billion USD | -0.3% |
| 2022 Q3 | 6.63 Billion USD | -12.15% |
| 2022 Q2 | 7.55 Billion USD | -0.48% |
| 2021 FY | 7.6 Billion USD | -2.87% |
| 2021 Q1 | 7.64 Billion USD | -2.31% |
| 2021 Q4 | 7.6 Billion USD | -0.21% |
| 2021 Q3 | 7.61 Billion USD | -0.18% |
| 2021 Q2 | 7.63 Billion USD | -0.18% |
| 2020 Q2 | 7.83 Billion USD | 23.14% |
| 2020 Q4 | 7.82 Billion USD | -0.08% |
| 2020 Q3 | 7.83 Billion USD | -0.06% |
| 2020 FY | 7.82 Billion USD | 22.94% |
| 2020 Q1 | 6.36 Billion USD | -0.03% |
| 2019 Q4 | 6.36 Billion USD | 0.05% |
| 2019 Q3 | 6.36 Billion USD | -0.12% |
| 2019 Q1 | 6.37 Billion USD | 7.46% |
| 2019 Q2 | 6.37 Billion USD | -0.12% |
| 2019 FY | 6.36 Billion USD | 7.26% |
| 2018 FY | 5.93 Billion USD | 0.03% |
| 2018 Q2 | 5.92 Billion USD | -0.02% |
| 2018 Q3 | 5.93 Billion USD | 0.05% |
| 2018 Q4 | 5.93 Billion USD | 0.09% |
| 2018 Q1 | 5.92 Billion USD | -0.09% |
| 2017 Q4 | 5.93 Billion USD | -0.06% |
| 2017 Q2 | 6.51 Billion USD | -0.0% |
| 2017 Q1 | 6.51 Billion USD | 0.02% |
| 2017 FY | 5.93 Billion USD | -8.87% |
| 2017 Q3 | 5.93 Billion USD | -8.84% |
| 2016 Q1 | 6.54 Billion USD | 0.29% |
| 2016 Q2 | 6.54 Billion USD | 0.04% |
| 2016 Q3 | 6.52 Billion USD | -0.21% |
| 2016 FY | 6.51 Billion USD | -0.13% |
| 2016 Q4 | 6.51 Billion USD | -0.26% |
| 2015 Q2 | 579.46 Million USD | -0.76% |
| 2015 Q3 | 6.53 Billion USD | 1027.66% |
| 2015 Q1 | 583.92 Million USD | -0.22% |
| 2015 Q4 | 6.52 Billion USD | -0.2% |
| 2015 FY | 6.52 Billion USD | 1014.41% |
| 2014 Q2 | 589.47 Million USD | -0.86% |
| 2014 Q3 | 587.19 Million USD | -0.39% |
| 2014 Q1 | 594.56 Million USD | -0.23% |
| 2014 FY | 585.19 Million USD | -1.8% |
| 2014 Q4 | 585.19 Million USD | -0.34% |
| 2013 Q3 | 698.27 Million USD | -4.29% |
| 2013 FY | 595.92 Million USD | -47.76% |
| 2013 Q4 | 595.92 Million USD | -14.66% |
| 2013 Q2 | 729.57 Million USD | -20.28% |
| 2013 Q1 | 915.14 Million USD | -19.78% |
| 2012 Q4 | 1.14 Billion USD | 2.62% |
| 2012 FY | 1.14 Billion USD | 7.21% |
| 2012 Q1 | 1.07 Billion USD | 1.44% |
| 2012 Q2 | 1.09 Billion USD | 1.41% |
| 2012 Q3 | 1.11 Billion USD | 1.56% |
| 2011 Q1 | 1.2 Billion USD | -0.26% |
| 2011 Q3 | 1.06 Billion USD | -10.95% |
| 2011 FY | 1.06 Billion USD | -11.59% |
| 2011 Q4 | 1.06 Billion USD | 0.0% |
| 2011 Q2 | 1.19 Billion USD | -0.45% |
| 2010 Q1 | 1.09 Billion USD | -0.42% |
| 2010 FY | 1.2 Billion USD | 9.42% |
| 2010 Q4 | 1.2 Billion USD | 11.43% |
| 2010 Q3 | 1.08 Billion USD | 0.02% |
| 2010 Q2 | 1.07 Billion USD | -1.41% |
| 2009 Q3 | 1.1 Billion USD | 0.09% |
| 2009 Q4 | 1.09 Billion USD | -0.12% |
| 2009 FY | 1.09 Billion USD | -1.18% |
| 2009 Q1 | 1.1 Billion USD | -0.33% |
| 2009 Q2 | 1.1 Billion USD | -0.82% |
| 2008 Q1 | 1.07 Billion USD | -31.33% |
| 2008 Q4 | 1.11 Billion USD | 5.74% |
| 2008 Q3 | 1.05 Billion USD | 0.29% |
| 2008 FY | 1.11 Billion USD | -28.78% |
| 2008 Q2 | 1.04 Billion USD | -2.2% |
| 2007 FY | 1.56 Billion USD | 1516.42% |
| 2007 Q1 | 61.19 Million USD | -36.72% |
| 2007 Q2 | 63.24 Million USD | 3.36% |
| 2007 Q3 | 1.56 Billion USD | 2366.96% |
| 2007 Q4 | 1.56 Billion USD | 0.18% |
| 2006 Q1 | 43.97 Million USD | 1.23% |
| 2006 Q2 | 44.52 Million USD | 1.25% |
| 2006 Q3 | 45.07 Million USD | 1.23% |
| 2006 FY | 96.69 Million USD | 122.57% |
| 2006 Q4 | 96.69 Million USD | 114.52% |
| 2005 Q4 | 43.44 Million USD | 1.21% |
| 2005 Q1 | 846.43 Million USD | -0.46% |
| 2005 Q2 | 42.4 Million USD | -94.99% |
| 2005 Q3 | 42.92 Million USD | 1.23% |
| 2005 FY | 43.44 Million USD | -94.89% |
| 2004 FY | 850.3 Million USD | -4.17% |
| 2004 Q3 | 845.7 Million USD | -2.37% |
| 2004 Q1 | 861.29 Million USD | -2.93% |
| 2004 Q2 | 866.22 Million USD | 0.57% |
| 2004 Q4 | 850.3 Million USD | 0.54% |
| 2003 Q3 | 39.04 Million USD | -2.02% |
| 2003 Q2 | 39.85 Million USD | -30.59% |
| 2003 FY | 887.27 Million USD | 1997.66% |
| 2003 Q4 | 887.27 Million USD | 2172.2% |
| 2003 Q1 | 57.41 Million USD | 35.74% |
| 2002 FY | 42.29 Million USD | -48.52% |
| 2002 Q3 | 72.74 Million USD | -5.43% |
| 2002 Q2 | 76.92 Million USD | -1.7% |
| 2002 Q1 | 78.25 Million USD | -4.75% |
| 2002 Q4 | 42.29 Million USD | -41.85% |
| 2001 Q3 | 102.05 Million USD | -0.98% |
| 2001 Q2 | 103.05 Million USD | -0.84% |
| 2001 Q1 | 103.92 Million USD | -4.93% |
| 2001 FY | 82.16 Million USD | -24.85% |
| 2001 Q4 | 82.16 Million USD | -19.49% |
| 2000 Q4 | 109.32 Million USD | 103.53% |
| 2000 FY | 109.32 Million USD | -3.31% |
| 2000 Q1 | 56.15 Million USD | -50.33% |
| 2000 Q3 | 53.71 Million USD | -1.48% |
| 2000 Q2 | 54.51 Million USD | -2.92% |
| 1999 FY | 113.06 Million USD | 82.8% |
| 1999 Q3 | 58.6 Million USD | -1.35% |
| 1999 Q4 | 113.06 Million USD | 92.94% |
| 1999 Q2 | 59.4 Million USD | -2.78% |
| 1999 Q1 | 61.1 Million USD | -1.21% |
| 1998 Q1 | 89.2 Million USD | -2.57% |
| 1998 Q4 | 61.84 Million USD | -24.85% |
| 1998 Q3 | 82.3 Million USD | 4.31% |
| 1998 Q2 | 78.9 Million USD | -11.55% |
| 1998 FY | 61.84 Million USD | -32.44% |
| 1997 Q3 | 68.4 Million USD | -1.16% |
| 1997 Q1 | 70.8 Million USD | 6.83% |
| 1997 Q2 | 69.2 Million USD | -2.26% |
| 1997 Q4 | 91.55 Million USD | 33.85% |
| 1997 FY | 91.55 Million USD | 38.15% |
| 1996 Q4 | 66.27 Million USD | 7.41% |
| 1996 Q1 | 41.6 Million USD | 20.6% |
| 1996 Q2 | 52.7 Million USD | 26.68% |
| 1996 Q3 | 61.7 Million USD | 17.08% |
| 1996 FY | 66.27 Million USD | 92.13% |
| 1995 Q4 | 34.49 Million USD | 11.99% |
| 1995 Q3 | 30.8 Million USD | 23.2% |
| 1995 Q2 | 25 Million USD | 0.0% |
| 1995 FY | 34.49 Million USD | 0.0% |
| 1995 Q1 | 25 Million USD | 0.0% |
| 1994 Q4 | - USD | 0.0% |
| 1994 Q1 | - USD | 0.0% |
| 1994 Q2 | - USD | 0.0% |
| 1994 Q3 | - USD | 0.0% |
| 1994 FY | - USD | 0.0% |
| 1993 Q1 | - USD | 0.0% |
| 1993 Q2 | - USD | 0.0% |
| 1993 Q4 | - USD | 0.0% |
| 1993 Q3 | - USD | 0.0% |
| 1993 FY | - USD | 0.0% |
| 1992 Q4 | - USD | 0.0% |
| 1992 FY | - USD | 0.0% |
| 1992 Q2 | - USD | 0.0% |
| 1992 Q3 | - USD | 0.0% |
| 1992 Q1 | - USD | 0.0% |
| 1991 Q3 | - USD | 0.0% |
| 1991 FY | - USD | 0.0% |
| 1991 Q2 | - USD | 0.0% |
| 1991 Q4 | - USD | 0.0% |
| 1991 Q1 | - USD | 0.0% |
| 1990 Q4 | - USD | 0.0% |
| 1990 FY | - USD | 0.0% |
| 1990 Q2 | - USD | 0.0% |
| 1990 Q1 | - USD | 0.0% |
| 1990 Q3 | - USD | 0.0% |
| 1989 Q4 | - USD | 0.0% |
| 1989 Q3 | - USD | 0.0% |
| 1989 FY | - USD | -100.0% |
| Name | Total Debt | Total Debt Difference |
|---|---|---|
| Thermo Fisher Scientific Inc. | 34.91 Billion USD | 78.984% |
| Agios Pharmaceuticals, Inc. | 56.98 Million USD | -12776.746% |
| Atara Biotherapeutics, Inc. | 57.87 Million USD | -12580.053% |
| Cara Therapeutics, Inc. | 43.16 Million USD | -16899.56% |
| uniQure N.V. | 138.4 Million USD | -5201.823% |
| Amicus Therapeutics, Inc. | 445.05 Million USD | -1548.815% |
| bluebird bio, Inc. | 330.32 Million USD | -2121.502% |
| Imunon, Inc. | 1.13 Million USD | -644001.21% |
| Dynavax Technologies Corporation | 256.91 Million USD | -2756.287% |
| Editas Medicine, Inc. | 36.53 Million USD | -19984.848% |
| Illumina, Inc. | 2.26 Billion USD | -224.412% |
| Iovance Biotherapeutics, Inc. | 1 Million USD | -733720.0% |
| IQVIA Holdings Inc. | 14.23 Billion USD | 48.435% |
| Mettler-Toledo International Inc. | 2.16 Billion USD | -238.514% |
| Myriad Genetics, Inc. | 145 Million USD | -4960.828% |
| Neurocrine Biosciences, Inc. | 428.4 Million USD | -1612.932% |
| Sarepta Therapeutics, Inc. | 1.39 Billion USD | -425.355% |
| Supernus Pharmaceuticals, Inc. | 41.52 Million USD | -17570.913% |
| Verastem, Inc. | 41.55 Million USD | -17558.156% |
| Walgreens Boots Alliance, Inc. | 9.55 Billion USD | 23.192% |
| Waters Corporation | 2.35 Billion USD | -211.533% |
| Nektar Therapeutics | 230.4 Million USD | -3084.969% |
| Perrigo Company plc | 4.07 Billion USD | -80.149% |
| Corbus Pharmaceuticals Holdings, Inc. | 20.88 Million USD | -35037.514% |
| Heron Therapeutics, Inc. | 173.75 Million USD | -4123.352% |
| Unity Biotechnology, Inc. | 26.99 Million USD | -27088.588% |
| BioMarin Pharmaceutical Inc. | 1.13 Billion USD | -547.179% |
| Sangamo Therapeutics, Inc. | 38.1 Million USD | -19158.346% |
| Evolus, Inc. | 126.54 Million USD | -5698.84% |
| Adicet Bio, Inc. | 17.7 Million USD | -41351.731% |
| Aclaris Therapeutics, Inc. | 3.07 Million USD | -238618.282% |
| Regeneron Pharmaceuticals, Inc. | 2.7 Billion USD | -171.494% |
| Esperion Therapeutics, Inc. | 540.94 Million USD | -1256.547% |
| FibroGen, Inc. | 170.45 Million USD | -4205.066% |
| Agilent Technologies, Inc. | 2.73 Billion USD | -168.307% |
| OPKO Health, Inc. | 326.56 Million USD | -2147.094% |
| Homology Medicines, Inc. | 44.05 Million USD | -16557.284% |
| Geron Corporation | 85.89 Million USD | -8442.824% |
| Alnylam Pharmaceuticals, Inc. | 2.39 Billion USD | -206.011% |
| Exelixis, Inc. | 189.94 Million USD | -3763.349% |
| Viking Therapeutics, Inc. | 1.26 Million USD | -582296.825% |
| Anavex Life Sciences Corp. | - USD | -Infinity% |
| Intellia Therapeutics, Inc. | 115.34 Million USD | -6261.902% |
| Zoetis Inc. | 6.8 Billion USD | -7.867% |
| Axsome Therapeutics, Inc. | 186.37 Million USD | -3837.394% |
| Abeona Therapeutics Inc. | 4.4 Million USD | -166601.499% |
| Vertex Pharmaceuticals Incorporated | 808.4 Million USD | -807.744% |
| Kala Pharmaceuticals, Inc. | 36.32 Million USD | -20102.626% |
| Ionis Pharmaceuticals, Inc. | 1.45 Billion USD | -404.851% |
| Corcept Therapeutics Incorporated | 151 Thousand USD | -4859635.099% |
| Halozyme Therapeutics, Inc. | 1.49 Billion USD | -389.459% |
| Blueprint Medicines Corporation | 774.12 Million USD | -847.938% |
| Insmed Incorporated | 1.2 Billion USD | -509.488% |
| TG Therapeutics, Inc. | 110.79 Million USD | -6523.223% |
| Incyte Corporation | 38.28 Million USD | -19066.297% |
| Emergent BioSolutions Inc. | 877.5 Million USD | -736.262% |